Inventor · disambiguated record
Marc Stefan Robillard
Also filed as: ROBILLARD MARC STEFAN
13 granted patents·18 pending applications·122 citations·filing 2005–2023
91Inventor score
Files withTAGWORKS PHARMACEUTICALS B V17ROBILLARD MARC STEFAN6KONINKL PHILIPS ELECTRONICS NV5KONINKL PHILIPS NV1LUB JOHAN1
Top patents by PatentIndex Score
31 records- 0194US9421274B2Bio-orthogonal drug activationROBILLARD MARC STEFAN·Filed 2012·Granted Aug 23, 2016·28 cites·4 claims
- 0292US10376594B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2015·Granted Aug 13, 2019·11 cites·25 claims
- 0391US9463256B2Pretargeting kit, method and agents used thereinLUB JOHAN·Filed 2011·Granted Oct 11, 2016·35 cites·11 claims
- 0489US10004810B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2016·Granted Jun 26, 2018·6 cites·4 claims
- 0587US9427482B2Agents for clearing biomolecules from circulationROSSIN RAFFAELLA·Filed 2011·Granted Aug 30, 2016·19 cites·10 claims
- 0686US9931408B2Bio-orthogonal drug activationROBILLARD MARC STEFAN·Filed 2012·Granted Apr 3, 2018·7 cites·27 claims
- 0785US10967069B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2019·Granted Apr 6, 2021·1 cites·34 claims
- 0885US2024091371A1Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
- 0983US9913921B2Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a dieneROBILLARD MARC STEFAN·Filed 2012·Granted Mar 13, 2018·11 cites·4 claims
- 1081US10927139B2Chemically cleavable groupTAGWORKS PHARMACEUTICALS B V·Filed 2013·Granted Feb 23, 2021·2 cites·37 claims
- 1176US11857636B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2021·Granted Jan 2, 2024·0 cites·17 claims
- 1274US8623325B2Azide modified charge sensitive channel proteinsROBILLARD MARC STEFAN·Filed 2009·Granted Jan 7, 2014·1 cites·10 claims
- 1373US11617799B2Cleavable tetrazine used in bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2017·Granted Apr 4, 2023·1 cites·41 claims
- 1467US12186405B2Cleavable tetrazine used in bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2022·Granted Jan 7, 2025·0 cites·33 claims
- 1563US2025114489A1Masked il12 proteinTAGWORKS PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
- 1660US2021002320A1Chemically cleavable groupTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1759US2022331458A1Agents for cleaving labels from biomolecules in vivoTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1856US2010227798A1Use of the staudinger ligation in in vivo assembly of a biologically active compoundKONINKL PHILIPS ELECTRONICS NV·Filed 2007·Application pending·0 cites
- 1954US2008267878A1Targeted Imaging And/Or Therapy Using The [3+2] Azide-Alkyne CycloadditionKONINKL PHILIPS ELECTRONICS NV·Filed 2006·Application pending·0 cites
- 2054US2024207434A1Methods for preparing cyclooctenes andconjugates thereofTAGWORKS PHARMACEUTICALS B V·Filed 2022·Application pending·0 cites
- 2151US2021308207A1Compounds comprising a linker for increasing transcyclooctene stabilityTAGWORKS PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
- 2249US2008075661A1Compounds, Kits and Methods for Use in Medical ImagingKONINKL PHILIPS ELECTRONICS NV·Filed 2005·Application pending·0 cites
- 2349US2008181847A1Targeted Imaging and/or Therapy Using the Staudinger LigationKONINKL PHILIPS ELECTRONICS NV·Filed 2005·Application pending·0 cites
- 2449US2022356169A1Tetrazines for high click release speed and yieldTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 2547US2023121556A1Compounds for fast and efficient click releaseTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 2647US2015147273A1Radiolabeled analog(s) of compound 0118 and use thereof in connection with pet and/or spect imaging to determine whether a pharmaceutical containing compound 0118 is a candidate cancer treatment for a patientKONINKL PHILIPS NV·Filed 2013·Application pending·0 cites
- 2746US2015297741A1Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2013·Application pending·0 cites
- 2846US2021299286A1Tetrazines for high click conjugation yield in vivo and high click release yieldTAGWORKS PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
- 2943US2008274057A1Staudinger Reaction in Imaging and Therapy and Kits for Use in Imaging and TherapyKONINKL PHILIPS ELECTRONICS NV·Filed 2006·Application pending·0 cites
- 3040US2012039803A1Pretargeting kit, method and agents used thereinROBILLARD MARC STEFAN·Filed 2010·Application pending·0 cites
- 3136US2012034161A1Pretargeting kit, method and agents used thereinROBILLARD MARC STEFAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc Stefan Robillard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →